Velphoro

Active Ingredient(s): Sucroferric Oxyhydroxide
FDA Approved: * November 27, 2013
Pharm Company: * VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE
Category: Hyperphosphatemia

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Velphoro Overview

Phosphate binders are medications used to reduce the absorption of phosphate and taken with meals and snacks. They are typically used in people with chronic kidney failure (CKF) as they often have difficulty getting rid of the phosphates that get into their blood (i.e., the serum phosphate in chronic kidney failure is typically elevated). Contents 1 Medical use 2 Adverse effects 3 Choice of agent 3.1 Types 4 Mechanism of action 5 References 6 External links 6.1 Common Phosphate Binder...

Read more Velphoro Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Phosphate_binders

Recent Velphoro Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Velphoro: (1 result)

Sorted by National Drug Code

• 49230-645 Velphoro 500 mg/1 Oral Tablet, Chewable by Fresenius Medical Care North America

Other drugs which contain Sucroferric Oxyhydroxide or a similar ingredient: (1 result)

• SUCROFERRIC OXYHYDROXIDE